Chester County News and Community Website
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients …
GSK Wins FDA Approval for Blenrep Combo in Advanced Multiple Myeloma Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has unveiled a major update to its Vaccine Track platform, expanding the interactive public data tool to include vaccination trends across 387 U.S. …
GSK Expands Vaccine Track With Metro-Level Data to Advance Adult Immunization Insights Read More PHILADELPHIA, PA — GSK plc has announced its sponsorship of the 2025 National Senior Games as part of its Sideline RSV campaign, a nationwide health education initiative aimed at informing adults …
GSK Highlights RSV Awareness Through National Senior Games Partnership and New TV Special Read More PHILADELPHIA, PA — GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster). The …
FDA Approves Prefilled Syringe for GSK’s Shingles Vaccine, Streamlining Immunization Process Read More PHILADELPHIA, PA — GSK plc has announced the start of shipments for its trivalent seasonal influenza vaccines, FLULAVAL and FLUARIX, to healthcare providers and pharmacies across the United States. The …
GSK Begins Shipping Flu Vaccines Ahead of 2025-26 Season Following FDA Approval Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) this week approved GSK‘s 200 mg/mL autoinjector of Benlysta (belimumab) for use in children aged five and older who are …
FDA Approves Benlysta Autoinjector for Pediatric Lupus Nephritis Treatment Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has introduced the Linked by Lupus: Optimal Care Initiative, a new program designed to improve the lives of individuals affected by lupus, with …
GSK Launches Linked by Lupus Initiative to Advance Care and Support Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with …
FDA Approves GSK’s Nucala for COPD Patients with Eosinophilic Phenotype Read More PHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 50-59 who …
Expanded Recommendation for GSK’s AREXVY Vaccine Targets Adults at Higher Risk for Severe RSV Read More PHILADELPHIA, PA — The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the inclusion of GSK’s PENMENVY vaccine in the adolescent meningococcal …
CDC Panel Recommends GSK’s New PENMENVY Vaccine for Adolescents Read More